Squarepoint Ops LLC Iovance Biotherapeutics, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 307,384 shares of IOVA stock, worth $2.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

307,384

Previous 257,543 19.35%

Holding current value

$2.51 Million

Previous $2.07 Million 39.76%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.28 - $11.9 $362,842 - $593,107	49,841 Added 19.35%	307,384 $2.89 Million
Q2 2024 Aug 14, 2024	BUY	$7.78 - $14.19 $2 Million - $3.65 Million	257,543 New	257,543 $2.07 Million
Q1 2023 May 15, 2023	BUY	$5.53 - $8.22 $230,224 - $342,215	41,632 New	41,632 $254,000
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $3.51 Million - $4.83 Million	368,310 New	368,310 $3.53 Million
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $137,463 - $394,938	-21,546 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $1.26 Million - $1.95 Million	-102,045 Reduced 82.57%	21,546 $359,000
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $1.5 Million - $2.51 Million	90,730 Added 276.1%	123,591 $2.36 Million
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $197,944 - $259,030	9,727 Added 42.05%	32,861 $810,000
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $213,808 - $432,985	-13,093 Reduced 36.14%	23,134 $602,000
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $1.04 Million - $1.91 Million	36,227 New	36,227 $1.15 Million
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $354,425 - $635,286	-12,640 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$27.75 - $36.3 $3.31 Million - $4.32 Million	-119,130 Reduced 90.41%	12,640 $416,000
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $3.4 Million - $5.12 Million	124,960 Added 1834.95%	131,770 $3.62 Million
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $850,185 - $1.69 Million	-43,510 Reduced 86.47%	6,810 $204,000
Q4 2019 Feb 14, 2020	BUY	$17.95 - $29.41 $279,876 - $458,560	15,592 Added 44.9%	50,320 $1.39 Million
Q3 2019 Nov 14, 2019	SELL	$17.99 - $26.0 $355,968 - $514,462	-19,787 Reduced 36.3%	34,728 $632,000
Q2 2019 Aug 14, 2019	SELL	$9.78 - $24.52 $2.76 Million - $6.92 Million	-282,112 Reduced 83.81%	54,515 $1.34 Million
Q1 2019 May 15, 2019	BUY	$8.41 - $11.26 $1.01 Million - $1.35 Million	120,175 Added 55.52%	336,627 $3.2 Million
Q4 2018 Feb 14, 2019	SELL	$7.51 - $11.93 $274,475 - $436,017	-36,548 Reduced 14.45%	216,452 $1.92 Million
Q3 2018 Nov 14, 2018	BUY	$11.25 - $17.7 $1.23 Million - $1.93 Million	109,000 Added 75.69%	253,000 $2.85 Million
Q2 2018 Aug 14, 2018	BUY	$12.45 - $16.95 $466,875 - $635,625	37,500 Added 35.21%	144,000 $1.84 Million
Q1 2018 May 15, 2018	BUY	$8.1 - $19.5 $749,687 - $1.8 Million	92,554 Added 663.66%	106,500 $1.8 Million
Q4 2017 Feb 14, 2018	SELL	$6.65 - $9.25 $194,579 - $270,655	-29,260 Reduced 67.72%	13,946 $112,000
Q3 2017 Nov 14, 2017	BUY	$4.45 - $8.55 $192,266 - $369,411	43,206	43,206 $335,000

Others Institutions Holding IOVA

# of Institutions

315

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.29B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Iovance Biotherapeutics, Inc. Transaction History